EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors

Sang-Soo Kim, Manish Moghe iD, Antonina Rait, Kathryn Donaldson iD, Joe B Harford, Esther H Chang iD

International Journal of Nanomedicine · 2024

DOI: 10.2147/ijn.s458323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von Sang-Soo Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA. Hauptthemen laut MEDLINE: SMARCB1 Protein, Rhabdoid Tumor, Genetic Therapy, Nanoparticles. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SMARCB1 ProteinRhabdoid TumorGenetic TherapyNanoparticlesNanomedicineAnimalsMiceCell Line, TumorHumansBrain NeoplasmsDisease Models, AnimalTeratomaCell ProliferationAntineoplastic AgentsLiposomes

Stichwörter der Autor:innen

SMARCB1atypical teratoid rhabdoid tumorgene therapylipid nanoparticlenanodelivery

Substanzen

SMARCB1 ProteinSMARCB1 protein, humanLipid NanoparticlesAntineoplastic AgentsLiposomes

Autor:innen und Institutionen

  • Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
  • SynerGene Therapeutics, Inc, Potomac, MD, USA.

ORCID-Profile: Manish Moghe, Kathryn Donaldson, Esther H Chang

Förderung

  • NCI NIH HHS

Zitieren

APA

Kim, S. S., Moghe, M., Rait, A., Donaldson, K., Harford, J. B., & Chang, E. H. (2024). SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s458323

Vancouver

Kim SS, Moghe M, Rait A, Donaldson K, Harford JB, Chang EH. SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s458323

BibTeX
@article{Kim2024,
  author = {Kim, Sang-Soo and Moghe, Manish and Rait, Antonina and Donaldson, Kathryn and Harford, Joe B and Chang, Esther H},
  title = {SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors},
  journal = {International Journal of Nanomedicine},
  year = {2024},
  doi = {10.2147/ijn.s458323}
}
Kostenlos starten →